Use of fluoroquinolones as prophylactic agents in patients with neutropenia
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 16 (1) , 135-139
- https://doi.org/10.1097/00006454-199701000-00038
Abstract
The use of fluorinated quinolone antibiotics to selectively decontaminate the gastrointestinal tract is a reasonable alternative to prevent infection in neutropenic patients. The fluoroquinolones represent ideal antibiotics with which to achieve the principles of selective decontamination by allowing colonization of anaerobes to inhibit the adherence, colonization and proliferation of potentially pathogenic aerobic flora.This report describes the prophylactic use of fluoroquinolones in neutropenic patients.The majority of studies of fluoroquinolone prophylaxis in neutropenic patients have shown a reduction in documented Gram-negative bacterial infections. However, Gram-positive infections, particularly those with viridans streptococci, present a major impediment to the use of single agent prophylaxis with a quinolone.Prophylaxis with fluoroquinolones in neutropenic patients was found to be advantageous, but it must be balanced against the risk of Gram-positive infections and the potential for antibiotic resistance.Keywords
This publication has 32 references indexed in Scilit:
- Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk FactorsClinical Infectious Diseases, 1994
- Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing FactorsClinical Infectious Diseases, 1992
- The contribution of Escherichia coli to microbial colonization resistanceJournal of Antimicrobial Chemotherapy, 1990
- Quinolone antimicrobial agents: Adverse effects and bacterial resistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemiaThe American Journal of Medicine, 1988
- The 4th EORTC Breast Cancer Working Conference, London, 1–3 July 1987European Journal of Cancer and Clinical Oncology, 1988
- Selective Antimicrobial Modulation as Propbylaxis Against Infection During Granulocytopenia: Trimetboprim-Sulfametboxazole vs. Nalidixic AcidThe Journal of Infectious Diseases, 1983
- Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trialThe Journal of Pediatrics, 1983
- Failure of Oral Trimethoprim-Sulfamethoxazole Prophylaxis in Acute LeukemiaNew England Journal of Medicine, 1982
- Successful Chemoprophylaxis forPneumocystis cariniiPneumonitisNew England Journal of Medicine, 1977